CSIC
AGN

Clifford Swan Investment Counsel’s Allergan plc AGN Stock Holding History

Clifford Swan Investment Counsel’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-26,485
Closed -$4.69M – 313
2020
Q1 		$4.69M Sell
26,485
-5,777
-18% -$1.09M 0.28% 94
2019
Q4 		$6.17M Sell
32,262
-4,788
-13% -$864K 0.3% 92
2019
Q3 		$6.24M Sell
37,050
-10,475
-22% -$1.71M 0.32% 87
2019
Q2 		$7.96M Buy
47,525
+568
+1% +$78.7K 0.42% 77
2019
Q1 		$6.88M Buy
46,957
+1,059
+2% +$154K 0.37% 83
2018
Q4 		$6.13M Sell
45,898
-655
-1% -$107K 0.37% 84
2018
Q3 		$8.87M Sell
46,553
-257
-0.5% -$47.2K 0.46% 70
2018
Q2 		$7.8M Buy
46,810
+7,206
+18% +$1.16M 0.44% 77
2018
Q1 		$6.67M Buy
39,604
+5,582
+16% +$936K 0.38% 82
2017
Q4 		$5.57M Sell
34,022
-2,291
-6% -$411K 0.3% 90
2017
Q3 		$7.44M Buy
36,313
+172
+0.5% +$40K 0.45% 75
2017
Q2 		$8.79M Buy
36,141
+2,171
+6% +$510K 0.55% 63
2017
Q1 		$8.12M Buy
33,970
+3,121
+10% +$727K 0.52% 63
2016
Q4 		$6.48M Sell
30,849
-3,369
-10% -$698K 0.43% 72
2016
Q3 		$7.88M Buy
34,218
+29,917
+696% +$7.31M 0.53% 64
2016
Q2 		$994K Sell
4,301
-9,073
-68% -$2.09M 0.07% 140
2016
Q1 		$3.58M Buy
13,374
+8,635
+182% +$2.47M 0.24% 90
2015
Q4 		$1.48M Buy
4,739
+3,094
+188% +$921K 0.1% 131
2015
Q3 		$447K Sell
1,645
-235
-13% -$72.2K 0.03% 197
2015
Q2 		$571K Sell
1,880
-539
-22% -$161K 0.04% 180
2015
Q1 		$720K Buy
+2,419
New +$690K 0.05% 163

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Clifford Swan Investment Counsel's AGN Position: Q2 2020 in Review

Clifford Swan Investment Counsel sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 26,485 shares — an estimated $4.69M sold.

Clifford Swan Investment Counsel first reported a position in AGN in Q1 2015 and held it in 21 quarters. The position peaked at $8.87M in Q3 2018. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Clifford Swan Investment Counsel reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Clifford Swan Investment Counsel sold 26,485 Allergan plc shares in Q2 2020, an estimated $4.69M.
  • Clifford Swan Investment Counsel first reported a position in Allergan plc in Q1 2015 and held it in 21 quarters.
  • Clifford Swan Investment Counsel's Allergan plc position peaked at $8.87M in Q3 2018.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Clifford Swan Investment Counsel's 13F filing for Q2 2020, filed 6 Aug 2020.